InsidersTradesSigma
Explore the full record of transactions filed by Barnett Eva Renee, Chief Financial Officer. Insider active across 1 companies, notably Immunovant, Inc.. Aggregated, 6 filings have been published. Total volume traded: €385k. The latest transaction was disclosed on 7 January 2022 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
6 of 6 declarations
Eva Renee Barnett is the Chief Financial Officer of Immunovant, Inc. She is responsible for the financial management of the company, including budgeting and financial performance analysis.